MedPath

A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer

Not Applicable
Completed
Conditions
Esophageal Neoplasms
Registration Number
NCT02182804
Lead Sponsor
King Chulalongkorn Memorial Hospital
Brief Summary

This descriptive cross sectional study aims to directly compare the diagnostic capability of the probed-based confocal laser endomicroscopy (pCLE) and the magnifying narrow band imaging (M-NBI) in the Lugol's voiding lesions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Age over 20 years
  • Having histological-confirmed diagnosis of head and neck cancer
  • Having no esophageal symptoms
Exclusion Criteria
  • Having index cancer of nasopharynx
  • History of esophageal surgery
  • Having esophageal stricture or obstruction
  • Having esophageal varices
  • Known case of esophageal cancer
  • Uncorrectable coagulopathy and thrombocytopenia
  • Pregnancy
  • Thyrotoxicosis
  • Creatinine clearance less than 30 ml/min
  • Allergy to iodine or fluorescein.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Accuracyan expected average of 2 weeks

Diagnostic performance of the pCLE and M-NBI in Lugol's voiding lesions size larger than 5 millimeters.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.